LOUISDERMA PARIS

Louisderma Paris® was founded with the vision of continuing to promote skin and hair health by creating new and improved types of treatments for doctors and patients. We work closely with the medical community to achieve this goal. We have leading physicians on our advisory board. Our technology has changed the game in regenerative medicine, such as the PLATELETE IMD: a user-friendly technology for skin rejuvenation. In recent years, Louisderma Paris® has developed new meso cocktail products tailored to different skin and hair types using special technologies such as VIXOEYE, GAMACTIL, LINUTRX, CELLIO, and LINUGLO. Today, our products and technology are marketed in over 30 countries worldwide. We will continue to redefine the aesthetic landscape by pushing boundaries through the development of innovative solutions in the fields of cosmetology and medical devices, while ensuring excellence in everything we do. The products of LOUISDERMA PARIS are manufactured under a quality management system that complies with the requirements of ISO 13485: 2016, ISO 22716 standards, and GMP regulations. All medical devices are regulated and certified under the Medical Device Regulation, with the EU-CE 0373 quality management system certificate.